Jeffrey Langland

3.1k total citations · 1 hit paper
58 papers, 2.5k citations indexed

About

Jeffrey Langland is a scholar working on Molecular Biology, Epidemiology and Virology. According to data from OpenAlex, Jeffrey Langland has authored 58 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 17 papers in Epidemiology and 13 papers in Virology. Recurrent topics in Jeffrey Langland's work include Herpesvirus Infections and Treatments (14 papers), Poxvirus research and outbreaks (13 papers) and RNA regulation and disease (11 papers). Jeffrey Langland is often cited by papers focused on Herpesvirus Infections and Treatments (14 papers), Poxvirus research and outbreaks (13 papers) and RNA regulation and disease (11 papers). Jeffrey Langland collaborates with scholars based in United States, Switzerland and China. Jeffrey Langland's co-authors include Bertram L. Jacobs, Barry L. Jacobs, Karen V. Kibler, Michael Heck, James K. Jancovich, Don Roth, Karen L. Denzler, Stacy D. White, Peter N. Kao and Carole R. Baskin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Jeffrey Langland

56 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

When Two Strands Are Better Than One: The Mediators and Modulators of the Cellular Responses to Double-Stranded RNA

1996 508 citations Bertram L. Jacobs, Jeffrey Langland Virology profile →

Peers

Countries citing papers authored by Jeffrey Langland

Since Specialization

Citations

This map shows the geographic impact of Jeffrey Langland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Langland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Langland more than expected).

Fields of papers citing papers by Jeffrey Langland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Langland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Langland. The network helps show where Jeffrey Langland may publish in the future.

Co-authorship network of co-authors of Jeffrey Langland

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Langland. A scholar is included among the top collaborators of Jeffrey Langland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Langland. Jeffrey Langland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In vitro evaluation the spectrum of antibacterial activity of botanical extracts and activity enhancement with outer membrane permeabilizers 2025 ·BMC Complementary Medicine and Therapies ·Clare R. Gregory, Jeffrey Langland	0
2	Antimicrobial Activity of Individual Volatile Compounds from Various Essential Oils 2024 ·Molecules ·(unknown), (unknown), Jeffrey Langland	10
3	Treatment of herpes zoster with botanical interventions 2021 ·(unknown), Jeffrey Langland	1
4	Antimicrobial activity of the volatile substances from essential oils 2021 ·BMC Complementary Medicine and Therapies ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jeffrey Langland	120
5	Anti-herpes virus activity of the carnivorous botanical, Sarracenia purpurea 2020 ·Scientific Reports ·Latha Kannan, Ashok Kumar, (unknown), Bertram L. Jacobs, Jeffrey Langland	10
6	Antiviral activity of metal chelates of caffeic acid and similar compounds towards herpes simplex, VSV-Ebola pseudotyped and vaccinia viruses 2018 ·Antiviral Research ·Jeffrey Langland, Bertram L. Jacobs, Carl E. Wagner, Guillermo Ruíz-Carrascoso, Thomas M. Cahill	74
7	Characterization of a PKR inhibitor from the pathogenic ranavirus, Ambystoma tigrinum virus, using a heterologous vaccinia virus system 2017 ·Virology ·Trung Huynh, James K. Jancovich, (unknown), Michael Heck, Jeffrey Langland, Bertram L. Jacobs	5
8	Monkeypox virus induces the synthesis of less dsRNA than vaccinia virus, and is more resistant to the anti-poxvirus drug, IBT, than vaccinia virus 2016 ·Virology ·William Arndt, Stacy D. White, Brian P. Johnson, Trung Huynh, (unknown), (unknown), (unknown), Karen V. Kibler, Jeffrey Langland, Bertram L. Jacobs	39
9	A Lack of Bioactive Predictability for Marker Compounds Commonly Used for Herbal Medicine Standardization 2016 ·PLoS ONE ·(unknown), (unknown), (unknown), (unknown), Robert F. Waters, Jeffrey Langland	12
10	Spectrum of Antimicrobial Activity Associated with Ionic Colloidal Silver 2012 ·The Journal of Alternative and Complementary Medicine ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), D.N. Payne, Bertram L. Jacobs, Robert F. Waters, Jeffrey Langland	23
11	Regulation of Inflammatory Gene Expression in PBMCs by Immunostimulatory Botanicals 2010 ·PLoS ONE ·Karen L. Denzler, Robert F. Waters, Bertram L. Jacobs, Yvan Rochon, Jeffrey Langland	37
12	Viral Double-stranded RNAs from Vaccinia Virus Early or Intermediate Gene Transcripts Possess PKR Activating Function, Resulting in NF-κB Activation, When the K1 Protein Is Absent or Mutated 2010 ·Journal of Biological Chemistry ·(unknown), Jeffrey Langland, Joanna L. Shisler	43
13	Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: Scarification vaccination 2008 ·Vaccine ·Garilyn Jentarra, Michael Heck, (unknown), Karen V. Kibler, Jeffrey Langland, Carole R. Baskin, Olga Ananieva, Yung Chang, Bertram L. Jacobs	66
14	Inhibition of PKR by RNA and DNA viruses 2006 ·Virus Research ·Jeffrey Langland, (unknown), Michael Heck, James K. Jancovich, Bertram L. Jacobs	177
15	Inhibition of PKR by vaccinia virus: role of the N- and C-terminal domains of E3L 2004 ·Virology ·Jeffrey Langland, Bertram L. Jacobs	87
16	Regulation of IL-2 Gene Expression and Nuclear Factor-90 Translocation in Vaccinia Virus-Infected Cells 2003 ·Journal of Interferon & Cytokine Research ·Jeffrey Langland, Peter N. Kao, Bertram L. Jacobs	3
17	The Role of the PKR-Inhibitory Genes, E3L and K3L, in Determining Vaccinia Virus Host Range 2002 ·Virology ·Jeffrey Langland, Bertram L. Jacobs	150
18	Developmental regulation of a plant encoded inhibitor of eukaryotic initiation factor 2α phosphorylation 1997 ·The Plant Journal ·Jeffrey Langland, (unknown), (unknown), Debabrata Saha, Don Roth	13
19	Polyanion regulation of the plant-encoded double-stranded RNA-dependent protein kinase (pPKR) 1996 ·Plant Physiology and Biochemistry ·Jeffrey Langland, (unknown), Don Roth	2
20	When Two Strands Are Better Than One: The Mediators and Modulators of the Cellular Responses to Double-Stranded RNA breakdown → 1996 ·Virology ·Bertram L. Jacobs, Jeffrey Langland	508

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact